Day One Biopharmaceuticals Inc (DAWN NASDAQ) stock market data APIs
$7.542
-0.06(-0.8%)
as of October 24, 2025
Try our APIs with
free plan!
Day One Biopharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
Prev. Close
7.542
Open
7.4813
High
7.5673
Low
7.3214
52 wk Range
5.635-16.76
Market Cap
754 M
Shares Outstanding
102 M
Revenue
188 M
EPS
-0.29
Beta
-1.263
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Day One Biopharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Day One Biopharmaceuticals Inc data using free add-ons & libraries
Get Day One Biopharmaceuticals Inc Fundamental Data
Day One Biopharmaceuticals Inc Fundamental data includes:
- Net Revenue: 188 M
- EBITDA: -108 806 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-05
- EPS/Forecast: -0.351
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Day One Biopharmaceuticals Inc News
New
Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025
BRISBANE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercial...
Goldman's 48 potential M&A candidates
[M&A - concept waiting for mergers and acquisitions.3D rendering on yellow background.] Deal activity will rise by 15% in 2026, according to Goldman Sachs. Strategist David Kostin says M&A activity ...
Monte Rosa Therapeutics (GLUE) Soars 44.1%: Is Further Upside Left in the Stock?
Monte Rosa Therapeutics GLUE shares soared 44.1% in the last trading session to close at $6.93. The move was backed by solid volume with far more shares changing hands than in a normal session. This c...
Piper Sandler Starts Coverage on Day One (DAWN) with Overweight Rating
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) is one of the Top 10 Stocks Under $10 That Could Triple. On August 19, Piper Sandler started coverage of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) w...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
